Skip to content
    Drishti.money
    Earnings calls

    Alembic Pharma concall ledger

    Every earnings call for APLLTD — management tone, guidance, KPIs and promise tracking, quarter by quarter.

    APLLTD · 6 transcripts · Healthcare · latest Q4 FY26
    Q3 FY26Published 05 Feb 2026Call held 05 Feb 2026

    APLLTD Q3 FY26 Earnings Call Transcript & Analysis

    Revenue₹1,876 cr+11% YoYEBITDA₹464 cr+20% YoYEBITDA Margin25%PAT₹168 cr+21% YoYGross Margin72%

    Revenue ₹1,876 cr (+11% YoY); EBITDA (pre-R&D, pre-exceptional) ₹464 cr (+20% YoY); EBITDA Margin (pre-R&D, pre-exceptional) 25%. Revenue grew 11% YoY to INR 1,876 crores.

    Read full transcript & analysis
    Q2 FY26Published 04 Nov 2025Call held 04 Nov 2025

    APLLTD Q2 FY26 Earnings Call Transcript & Analysis

    Revenue₹1,910 cr+16% YoYEBITDA Margin26%PAT₹185 cr+30% YoYGross Margin73%Net Debt₹1,280 cr

    Revenue ₹1,910 cr (+16% YoY); EBITDA Margin (before R&D) 26%; PAT (before exceptional) ₹185 cr (+30% YoY). Revenue grew 16% YoY to ₹1,910 crores, driven by volume growth and new launches.

    Read full transcript & analysis